Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Sousa Manso

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scientific Reports|May 14, 2016
Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screensNadya Velikova, Simone Fulle, Ana Sousa Manso, et al.
Scientific Reports|June 19, 2024
Unveiling new genetic insights in rheumatoid arthritis for drug discovery through Taxonomy3 analysisJustyna Kozlowska, Neil Humphryes-Kirilov, Anastasia Pavlovets, et al.
Scientific Reports|October 14, 2021
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane markerMarta Poblocka, Akang Leonard Bassey, Victoria M Smith, et al.
Plos Pathogens|March 22, 2014
The role of host and microbial factors in the pathogenesis of pneumococcal bacteraemia arising from a single bacterial cell bottleneckAlice Gerlini, Leonarda Colomba, Leonardo Furi, et al.
Nature Communications|October 1, 2014
A random six-phase switch regulates pneumococcal virulence via global epigenetic changesAna Sousa Manso, Melissa H Chai, John M Atack, et al.
The Journal of Biological Chemistry|July 18, 2021
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in miceAndrew C Pearce, Mark J Bamford, Ruth Barber, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scientific Reports|May 14, 2016
Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screensNadya Velikova, Simone Fulle, Ana Sousa Manso, et al.
Scientific Reports|June 19, 2024
Unveiling new genetic insights in rheumatoid arthritis for drug discovery through Taxonomy3 analysisJustyna Kozlowska, Neil Humphryes-Kirilov, Anastasia Pavlovets, et al.
Scientific Reports|October 14, 2021
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane markerMarta Poblocka, Akang Leonard Bassey, Victoria M Smith, et al.
Plos Pathogens|March 22, 2014
The role of host and microbial factors in the pathogenesis of pneumococcal bacteraemia arising from a single bacterial cell bottleneckAlice Gerlini, Leonarda Colomba, Leonardo Furi, et al.
Nature Communications|October 1, 2014
A random six-phase switch regulates pneumococcal virulence via global epigenetic changesAna Sousa Manso, Melissa H Chai, John M Atack, et al.
The Journal of Biological Chemistry|July 18, 2021
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in miceAndrew C Pearce, Mark J Bamford, Ruth Barber, et al.
Pageof 1